Condition: Pre-Eclampsia · Sponsor: University Hospital, Bordeaux
A large number of studies on MVs from syncytiotrophoblasts support the hypothesis of their involvement in pre-eclampsia, via their multiple effects, among others as pro-coagulant, immuno-stimulatory and anti-angiogenic factors. The main objective is to compare the total concentration of the main populations of MVs in the maternal blood of a population of pre-eclamptic patients to those of a population of non-pre-eclamptic patients.
This description comes directly from the study's public registry record.
Loic Sentilhes, MD, PhD · +335 57 82 23 36 · loic.sentilhes@chu-bordeaux.fr
Alain Brisson, PhD · a.brisson@cbmn.u-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU Bordeaux | Bordeaux, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05675969